- Home
- CAVA vs RVMD Comparison
CAVA vs RVMD Comparison
Compare CAVA & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CAVA
- RVMD
- Stock Information
- Founded
- CAVA 2006
- RVMD 2014
- Country
- CAVA United States
- RVMD United States
- Employees
- CAVA N/A
- RVMD N/A
- Industry
- CAVA Restaurants
- RVMD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CAVA Consumer Discretionary
- RVMD Health Care
- Exchange
- CAVA Nasdaq
- RVMD Nasdaq
- Market Cap
- CAVA 9.0B
- RVMD 7.4B
- IPO Year
- CAVA 2023
- RVMD 2020
- Fundamental
- Price
- CAVA $74.62
- RVMD $39.66
- Analyst Decision
- CAVA Buy
- RVMD Strong Buy
- Analyst Count
- CAVA 14
- RVMD 12
- Target Price
- CAVA $118.07
- RVMD $68.67
- AVG Volume (30 Days)
- CAVA 3.5M
- RVMD 1.7M
- Earning Date
- CAVA 05-15-2025
- RVMD 08-06-2025
- Dividend Yield
- CAVA N/A
- RVMD N/A
- EPS Growth
- CAVA 274.67
- RVMD N/A
- EPS
- CAVA 1.20
- RVMD N/A
- Revenue
- CAVA $1,036,533,000.00
- RVMD N/A
- Revenue This Year
- CAVA $26.28
- RVMD N/A
- Revenue Next Year
- CAVA $21.53
- RVMD $241.39
- P/E Ratio
- CAVA $62.12
- RVMD N/A
- Revenue Growth
- CAVA 32.11
- RVMD N/A
- 52 Week Low
- CAVA $70.00
- RVMD $29.17
- 52 Week High
- CAVA $172.43
- RVMD $62.40
- Technical
- Relative Strength Index (RSI)
- CAVA 30.45
- RVMD 49.08
- Support Level
- CAVA $72.36
- RVMD $38.57
- Resistance Level
- CAVA $77.40
- RVMD $42.40
- Average True Range (ATR)
- CAVA 2.85
- RVMD 1.38
- MACD
- CAVA -0.25
- RVMD -0.16
- Stochastic Oscillator
- CAVA 20.16
- RVMD 28.46
About CAVA CAVA Group Inc.
Cava Group Inc owns and operates a chain of restaurants. It is the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: CAVA and Zoes Kitchen. The company generates all of its revenue from the CAVA segment.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.